M&A Deal Summary |
|
|---|---|
| Date | 2013-04-02 |
| Target | Totect |
| Sector | Life Science |
| Buyer(s) | Biocodex USA |
| Sellers(s) | Apricus Biosciences |
| Deal Type | Divestiture |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1953 |
| Sector | Life Science |
Biocodex USA is an independent multinational pharmaceutical company, dedicated to providing its customers with meaningful health care solutions, with an emphasis on gastroenterology and oncology supportive care.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 4 |
| Sector: Life Science M&A | 1 of 4 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: United States M&A | 1 of 2 |
| Year: 2013 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-03-02 |
Totect
United States Totect (dexrazoxane HCI) is an emergency medicine used to reverse the toxic effects of anthracycline anti-cancer treatment. Totect® reverses this damage, allowing patients to continue their essential anti-cancer treatment. |
Sell | - |
| Category | Company |
|---|---|
| Founded | 1987 |
| Sector | Life Science |
| Revenue | 6M USD (2016) |
Apricus Biosciences is a specialty pharmaceutical company with commercial products and a broad pipeline across numerous therapeutic classes. Apricus Biosciences was founded in 1987 and is based in San Diego, California.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2013 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-12-29 |
Topotarget USA
Rockaway, New Jersey, United States Topotarget USA, Inc. is a biotechnology company. |
Buy | - |
